Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AVARA Rx vs Kin Meds

AVARA Rx
Graded #267

Lower grade

vs+10.100000000000009
Kin Meds
Graded #75

Higher grade

The verdict

Kin Meds takes it — 72.9/100 to 62.8/100.

Kin Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueKin Meds +31
43
74
Dose & formulationKin Meds +16
77
93
Clinical oversightAVARA Rx +2
76
74
Labs & monitoringKin Meds +1
52
53
FulfillmentAVARA Rx +5
77
72
Contract termsEven
55
55
AVARA Rx · left barKin Meds · right bar

The numbers

MetricAVARA RxKin Meds
WeighScore62.8/10072.9/100
GradeCC
Scorecard rank#267#75
Semaglutide$229/mo (starting dose, compounded)$149/mo (brand Wegovy)
Tirzepatide$279/mo (starting dose, compounded)$149/mo (brand Zepbound)
CoverageAll 50 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
AVARA Rx

Graded #267 · C

Strengths

  • Names its pharmacy partner (DiRx Health, Ft Lauderdale FL) — buyers can independently verify its licensure
  • Names its clinical network (Beluga Health) — you can research the platform handling your prescriptions
  • All 50 states explicitly listed on the FAQ — uncommon vs peers that just say 'nationwide'
  • Patient-friendly refunds — full refund if a provider disqualifies you, partial if a weaker dose is prescribed
  • LegitScript verification badge displayed; pharmacy claims NABP-accredited facilities

Where it loses points

  • Operating legal entity not disclosed — only a Sheridan, WY registered-agent-style address surfaced
  • Dose pricing not itemized — only 'starting at $229' semaglutide and 'starting at $279' tirzepatide
  • LegitScript certification number not shown — badge only, so no direct lookup
  • No named medical director (Beluga Health is the network, not a named MD)
  • Lab work requirements not specified, and consultation fee not broken out from medication cost
Kin Meds

Graded #75 · C

Strengths

  • Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
  • Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
  • LegitScript verified
  • Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
  • Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health

Where it loses points

  • Legal entity name and state of incorporation not publicly disclosed
  • The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
  • Per-state availability not listed
  • $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
  • Lab work and dose-titration support not clearly described

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard